ѻýҕl

Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes

<ѻýҕl class="mpt-content-deck">— News and commentary from the endocrinology world
MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

More than , representing around 98 million Americans, but 81% of them don't know it, the CDC said as part of a national PSA to raise awareness.

The federal government's dietary guidelines may soon warn . (Washington Post)

Two phase II trials found the investigative oral drug LUM-201 significantly bolstered height velocity in , developer Lumos Pharma announced.

Following a debate at the American Medical Association's (AMA) interim meeting of its House of Delegates a few days ago, the organization of new obesity treatments.

Smoking tobacco was linked with an increased risk for , particularly for those with a familial risk. (Lancet Regional Health Europe)

Three people have reportedly been hospitalized in the U.S. after (Ozempic, Wegovy). (CBS News)

Women who slept only 6 hours a night for 6 weeks had , which was independent of adiposity. (Diabetes Care)

Novo Nordisk said it will , but will keep its other long-acting insulin, Tresiba, on the market. (Reuters)

is one of the main driving factors linking the conditions with pancreatic cancer. (Cell Metabolism)

A longitudinal study showed the quickly declined after ceasing hormonal contraceptive use. (Blood)

An Oklahoma woman after her Apple watch alerted her that she was in atrial fibrillation. (New York Post)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.